Asthma is a common condition in which airways swell becoming narrower and leading to difficulties breathing. Symptoms include wheezing, coughing, tightness in the chest and shortness of breath. One in twelve people in the US are afflicted with asthma at some point in their lives, according to figures from the CDC.
Asthma is a chronic condition with a number of possible causes and triggers. Allergies to dust, pet hair or pollen or a respiratory infection are among these. Patients diagnosed with asthma should avoid potential triggers where possible.
Many different medications are used to treat asthma, the most common of which are in inhaler form. Different inhalers are available, including preventative and quick relief varieties. Drugs used to treat asthma include: beta agonist inhalers such as Ventolin, mast cell stabilizers, leukotriene receptor antagonists, methylxanthines, 5-lipoxygenase inhibitors, and corticosteroids such as prednisone.
What do you need to know about allergy season 2019? The end of winter and start of spring can be a wonderful time of year, bringing warmer weather and longer days and the promise of summer to come but for children with hay fever, the onset of spring marks the start of an annual ordeal as seasonal...
Read MoreDo you struggle with asthma in the winter months? If so, you are not alone. Asthma affects more than 26 million Americans and is the most common chronic disease among children, according to figures from the Centers for Disease Control and Prevention (CDC). The cold weather and cold air that comes...
Read MoreEvery home needs a well-stocked medicine cabinet and this is especially true during the winter months when the common cold, flu and other winter ailments are particularly prevalent. While there is no cure for the common cold, there are many over-the-counter drugs to reduce those unpleasant cold...
Read MoreAre you one of the many people in the United States planning to enjoy a smoke-free 2019? A new year comes with the promise of a clean slate and the opportunity to make resolutions to improve your quality of life, leaving you a healthier, stronger and happier person. A YouGov NY poll conducted last...
Read MoreDo you have asthma and live near a busy road? If so, you may be one of those whose genetic profile means you are more susceptible to severe asthma symptoms exacerbated by traffic pollution… Around 26 million people in the US suffer from asthma, the equivalent to one in 13 Americans, but new...
Read MoreA new treatment option will soon be available for children aged five and over with asthma following the US Food and Drug Administration’s (FDA) decision to expand its approval of the GlaxoSmithKline (GSK) Arnuity Ellipta (fluticasone furoate) inhaler. The medication was first approved...
Read MoreGlaxoSmithKline’s once-daily triple therapy, the Trelegy Ellipta (fluticasone furoate, umeclidinium, vilanterol), is superior to dual combination therapies in reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations, new research...
Read MoreAsthma management among children has improved in recent years, with a smaller percentage of children hospitalized as a result of the condition, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC). Since the last study, the percentage of...
Read MoreThe US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...
Read MoreThe US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD). Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...
Read MoreHalf the respondents to a recent survey are aware of what pneumococcal disease is, but less than one-third were vaccinated against the condition. The poll, conducted by the Asthma and Allergy Foundation of America (AAFA), revealed a significant proportion of at-risk respondents were not immunized...
Read MorePatients taking medication for asthma have been reminded to keep up-to-date with vaccinations against pneumococcal disease. The Asthma and Allergy Foundation of America (AAFA) released the warning following a survey, which revealed many at-risk patients with asthma were unaware of their vaccination...
Read MoreNearly a month into spring and as plants start to bloom and we edge towards summer, many Americans are struggling with the return of their seasonal allergies and the high pollen count. Roughly 8 percent of people over the age of 18 in the United States suffer from hay fever, according to the...
Read MoreGlaxoSmithKline (GSK) has issued a voluntary Class II recall for three batches of its Ventolin HFA 200D inhalers, totaling over 593,000 units. The recall only affects hospitals, pharmacies, wholesalers and retailers and will not require patients to return their medication. Ventolin inhalers are...
Read MoreThe cold wintery weather can be the cause or trigger for a variety of health issues and problems. Everyday complaints such as the common cold and flu are more frequent, as are hospital acquired infections and viral infections such as norovirus. The cold months of the year also bring a higher risk...
Read More
